Minetto, P., Candoni, A., Guolo, F., Clavio, M., Zannier, M. E., Miglino, M., . . . Lemoli, R. M. (2020). Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden. Cancers (Basel).
Style de citation ChicagoMinetto, Paola, et al. "Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden." Cancers (Basel) 2020.
Style de citation MLAMinetto, Paola, et al. "Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden." Cancers (Basel) 2020.